Sphingolipids as a Novel Therapeutic Target in Radiation-Induced Lung Injury
Open Access
- 9 August 2021
- journal article
- review article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 79 (3) , 509-516
Abstract
Radiation-induced lung injury (RILI) is a potential complication of thoracic radiotherapy that can result in pneumonitis or pulmonary fibrosis and is associated with significant morbidity and mortality. The pathobiology of RILI is complex and includes the generation of free radicals and DNA damage that precipitate oxidative stress, endothelial cell (EC), and epithelial cell injury and inflammation. While the cellular events involved continue to be elucidated and characterized, targeted and effective therapies for RILI remain elusive. Sphingolipids are known to mediate EC function including many of the cell signaling events associated with the elaboration of RILI. Sphingosine-1-phosphate (S1P) and S1P analogs enhance EC barrier function in vitro and have demonstrated significant protective effects in vivo in a variety of acute lung injury models including RILI. Similarly, statin drugs that have pleiotropic effects that include upregulation of EC S1P receptor 1 (S1PR1) have been found to be strongly protective in a small animal RILI model. Thus, targeting of EC sphingosine signaling, either directly or indirectly, to augment EC function and thereby attenuate EC permeability and inflammatory responses, represents a novel and promising therapeutic strategy for the prevention or treatment of RILI.Keywords
This publication has 43 references indexed in Scilit:
- A Sphingosine 1–Phosphate 1 Receptor Agonist Modulates Brain Death–Induced Neurogenic Pulmonary InjuryAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Role of sphingolipids in murine radiation‐induced lung injury: protection by sphingosine 1‐phosphate analogsThe FASEB Journal, 2011
- Simvastatin Attenuates Radiation-Induced Murine Lung Injury and Dysregulated Lung Gene ExpressionAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- The Sphingosine Kinase 1 Inhibitor 2-(p-Hydroxyanilino)-4-(p-chlorophenyl)thiazole Induces Proteasomal Degradation of Sphingosine Kinase 1 in Mammalian CellsJournal of Biological Chemistry, 2010
- Differential Effects of Sphingosine 1–Phosphate Receptors on Airway and Vascular Barrier Function in the Murine LungAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Simvastatin attenuates ventilator-induced lung injury in miceCritical Care, 2010
- Synthetic Analogs of FTY720 [2-Amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] Differentially Regulate Pulmonary Vascular Permeability in Vivo and in VitroThe Journal of Pharmacology and Experimental Therapeutics, 2009
- GADD45a is a novel candidate gene in inflammatory lung injury via influences on Akt signalingThe FASEB Journal, 2009
- Sphingosine 1-phosphate rescues canine LPS-induced acute lung injury and alters systemic inflammatory cytokine production in vivoTranslational Research, 2008
- Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibitionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008